In a Thursday report, analyst Yin Shao Yang says that while GENS may have ceded mass market share in 1Q17, he believes it will regain this in 2Q.
SINGAPORE (May 4): Maybank Kim Eng Research continues to rate Genting Singapore (GENS) at “buy” with a higher price target of $1.25 from $1.10 previously with catalysts expected from a potential Japanese casino licence.
The casino and resort operator is due to announce its 1Q17 results next week on May 12.
